Identifying circulating tumor stem cells that matter: The key to prognostication and therapeutic targeting

Journal of Clinical Oncology

Volumn 29, Issue 21, 2011, Pages 2946-2947

  Faltas, Bishoy ^a   Zeidan, Amer ^b   Peters, Kristi ^c   Das, Avisnata ^c   Joudeh, Jamal ^c   Navaraj, Arunasalam ^c   Dolloff, Nathan G ^c   Harvey, Harold A ^c   Jiang, Yixing ^c   Allen, Joshua E ^c   Dicker, David T ^c   El Deiry, Wafik S ^c  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c PENN STATE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CARCINOEMBRYONIC ANTIGEN; CD133 ANTIGEN; CYTOKERATIN;

CANCER STEM CELL; CARCINOGENICITY; CELL SURVIVAL; COLORECTAL CANCER; GENE EXPRESSION; GLIOMA CELL; LETTER; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

COLORECTAL NEOPLASMS; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79960731600     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.6179     Document Type: Letter

References (12)

1. Iinuma H, Watanabe T, Mimori K, et al: Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 29:1547-1555, 2011
2. Monteiro J, Fodde R: Cancer stemness and metastasis: Therapeutic consequences and perspectives. Eur J Cancer 46:1198-1203, 2010
3. Allen JE, El-Deiry WS: Circulating tumor cells and colorectal cancer. Curr Colorectal Cancer Rep, 6:212-220, 2010
4. Shmelkov SV, Butler JM, Hooper AT, et al: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118:2111-2120, 2008 (Pubitemid 351872330)
5. Wang J, Sakariassen PØ, Tsinkalovsky O, et al: CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122:761-768, 2008
6. LaBarge MA, Bissell MJ: Is CD133 a marker of metastatic colon cancer stem cells? J Clin Invest 118:2021-2024, 2008
7. Ko Y, Klinz M, Totzke G, et al: Limitations of the reverse transcriptionpolymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin Cancer Res 4:2141-2146, 1998 (Pubitemid 28415660)
8. Peters KL, Allen JE, Dicker DT, et al: CTC profiling: Integration of biomarker analysis with current Veridex CellSearch technology. 102nd American Association for Cancer Research annual meeting, Orlando, FL, April 2-6, 2011 (abstr 3818)
9. Das A, Allen JE, Dicker DT, et al: Quantum dot multiplexing of prognostic marker and stem cell marker expression in colorectal cancer circulating tumor cells. 102nd American Association for Cancer Research annual meeting, Orlando, FL, April 2-6, 2011 (abstr 5248)
10. Navaraj A, Dicker DT, Dolloff N, et al: Multiplexed detection of phospho- ERK as a marker of H-Ras signaling, EGFR and cancer stem cell marker expression in breast cancer cells recovered from human blood. 102nd American Association for Cancer Research annual meeting, Orlando, FL, April 2-6, 2011 (abstr LB-57)
11. ClinicalTrials.gov: Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells. http://clinicaltrials.gov/ct2/show/NCT01286883?term= NCT01286883&rank=1
12. Sleeman JP, Nazarenko I, Thiele W: Do all roads lead to Rome? Routes to metastasis development. Int J Cancer 128:2511-2526, 2011